Increases LC3 levels;Promotes the association of Beclin-1 and Bcl-2;Blocks V-ATPase in B-cell acute lymphoblastic leukemia (697 cells). Here, MAP1LC3A is linked to B-cell acute lymphoblastic leukemia.